LOTUS Edge Valve System

DEVICE3 trials

Sponsors

Boston Scientific Corporation

Conditions

Aortic StenosisAortic Valve Stenosis

Unknown Phase

Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement

TerminatedNCT02202434

Boston Scientific CorporationAortic Stenosis

Start: 2014-09-22End: 2021-05-21Updated: 2021-12-17

REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System

TerminatedNCT02854319

Boston Scientific CorporationAortic Valve Stenosis

Start: 2016-09-07End: 2018-03-13Updated: 2018-05-31

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

TerminatedNCT03618095

Boston Scientific CorporationAortic Valve Stenosis

Start: 2019-01-14End: 2021-03-31Updated: 2022-12-27

Related Papers

Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR

JAMA Network Open2022-10-275 citations

Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement

Journal of the American Heart Association2020-08-2821 citations

Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial.

2019-10-2356 citations

Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves

JAMA Cardiology2019-02-2751 citations

Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk

Circulation2018-03-1225 citations

Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis

JAMA2018-01-02162 citations